AU7683391A - Modified interleukin-1 inhibitors - Google Patents

Modified interleukin-1 inhibitors

Info

Publication number
AU7683391A
AU7683391A AU76833/91A AU7683391A AU7683391A AU 7683391 A AU7683391 A AU 7683391A AU 76833/91 A AU76833/91 A AU 76833/91A AU 7683391 A AU7683391 A AU 7683391A AU 7683391 A AU7683391 A AU 7683391A
Authority
AU
Australia
Prior art keywords
inhibitors
modified interleukin
interleukin
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76833/91A
Inventor
Donald B Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU7683391A publication Critical patent/AU7683391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
AU76833/91A 1990-04-27 1991-04-03 Modified interleukin-1 inhibitors Abandoned AU7683391A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51546890A 1990-04-27 1990-04-27
US515468 1990-04-27

Publications (1)

Publication Number Publication Date
AU7683391A true AU7683391A (en) 1991-11-27

Family

ID=24051476

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76833/91A Abandoned AU7683391A (en) 1990-04-27 1991-04-03 Modified interleukin-1 inhibitors

Country Status (2)

Country Link
AU (1) AU7683391A (en)
WO (1) WO1991017184A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651955B2 (en) * 1989-11-29 1994-08-11 Amgen, Inc. Production of recombinant human interleukin-1 inhibitor

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
ATE194384T1 (en) 1989-09-12 2000-07-15 Hoffmann La Roche TNF-BINDING PROTEINS
IT1262898B (en) * 1992-03-23 1996-07-22 PROTEIN RECOMBINANT ANTIGENS WITH INCREASED IMMUNOGENICITY CONTAINING THE PEPTIDE REPRESENTED BY THE VQGEESNDK SEQUENCE
AU671116B2 (en) * 1992-03-30 1996-08-15 Immunex Corporation Fusion proteins comprising tumor necrosis factor receptor
AU1513495A (en) * 1993-12-14 1995-07-03 University Of Pittsburgh Systemic gene treatment of connective tissue diseases
US5608035A (en) * 1994-02-02 1997-03-04 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5880096A (en) * 1994-02-02 1999-03-09 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5786331A (en) * 1994-02-02 1998-07-28 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
US5861476A (en) * 1994-02-02 1999-01-19 Affymax Technologies N.V. Peptides and compounds that bind to the IL-1 receptor
IT1269989B (en) * 1994-09-21 1997-04-16 Dompe Spa IL-1 RECEPTOR ANTAGONISTS WITH INCREASED INHIBITORY ACTIVITY
US5837495A (en) * 1994-10-13 1998-11-17 Applied Research Systems Ars Holding N.V. DNA encoding interleukin-1 antagonist
IT1270662B (en) * 1994-10-13 1997-05-07 Applied Research Systems INTERLEUCHIN-1 ANTAGONIST
US5981713A (en) * 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
KR20040010739A (en) 1996-02-09 2004-01-31 암젠 인코포레이티드 Fusion protein comprising interleukin-1 receptor antagonist and pharmaceutical composition thereof
ES2615357T3 (en) 1996-12-06 2017-06-06 Amgen Inc. Combination therapy using an IL-1 inhibitor to treat IL-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
GB9927801D0 (en) * 1999-11-24 2000-01-26 Danisco Method
EP2329842A3 (en) 2000-05-12 2011-07-27 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
JP2004519230A (en) * 2001-02-06 2004-07-02 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング Modified interleukin-1 receptor antagonist with reduced immunogenicity (IL-1RA)
PL222211B1 (en) 2001-06-26 2016-07-29 Amgen Fremont Inc Antibodies to opgl
WO2003014703A2 (en) * 2001-08-09 2003-02-20 Curagen Corporation Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
NZ593428A (en) 2002-09-06 2013-01-25 Amgen Inc Therapeutic human anti-il-1r1 monoclonal antibody
AR056806A1 (en) 2005-11-14 2007-10-24 Amgen Inc RANKL- PTH / PTHRP ANTIBODY CHEMICAL MOLECULES
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
GB0708376D0 (en) 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
EP2217258B1 (en) 2007-11-14 2014-03-26 General Regeneratives Limited Use of interleukin-1 receptor antagonist as a myeloprotective agent
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN101690801B (en) 2009-10-26 2012-08-01 上海交通大学 Application of interleukin-1 receptor antagonist and medicinal composition thereof
NZ605928A (en) 2010-07-29 2015-02-27 Eleven Biotherapeutics Inc Chimeric il-1 receptor type i agonists and antagonists
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
WO2013170636A1 (en) 2012-05-18 2013-11-21 爱德迪安（北京）生物技术有限公司 Protein and protein conjugate for diabetes treatment, and applications thereof
JP6450364B2 (en) 2013-03-13 2019-01-09 セセン バイオ， インコーポレイテッド Chimeric cytokine formulations for ocular delivery
EP3068438A1 (en) 2013-11-11 2016-09-21 Ascendis Pharma Relaxin Division A/S Relaxin prodrugs
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188550B (en) * 1986-02-07 1988-01-14 Sclavo Spa SYNTHETIC PEPTIDE WITH INTERLEUKINA 1 HUMAN ACTIVITY
DE3855747T2 (en) * 1987-08-26 1997-06-12 Biogen Inc BIOLOGICAL MATERIALS, THEIR PRODUCTION AND USE IN THERAPY
KR0148009B1 (en) * 1988-05-27 1998-08-01 그래고리 비. 아보트 Interleukin-1 inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651955B2 (en) * 1989-11-29 1994-08-11 Amgen, Inc. Production of recombinant human interleukin-1 inhibitor

Also Published As

Publication number Publication date
WO1991017184A1 (en) 1991-11-14

Similar Documents

Publication Publication Date Title
AU7683391A (en) Modified interleukin-1 inhibitors
AU639126B2 (en) Oxorapamycin
AU5533094A (en) Enzyme inhibitors
AU8791591A (en) Tnf-muteins
AU8292091A (en) Tnf inhibitors
AU4183993A (en) Easel
AU7846991A (en) Aminobenzodiazepines
OA09631A (en) Interleukin-1 inhibitors
AU7150991A (en) Aromatase inhibitors
AU7410191A (en) Novel platelet-aggregation inhibitors
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7956191A (en) Transportsystem
AU1556892A (en) 2-substituted-2-imidazolines
AU1080292A (en) Ige-receptor-antibodies
AU7726391A (en) Slitterscorer
AU8769291A (en) Deoxyhypusyl hydroxylase inhibitors
AU601336B2 (en) Amplifier
AU7566691A (en) Compostor
AU8740291A (en) 3d-spectacles
AU8694291A (en) Ester inhibitors
AU7587991A (en) Electrodermatome
AU4553889A (en) Dopamine-beta-hydroxylase inhibitors
AU8984191A (en) Thiadiazinones
AU4553689A (en) Dopamine-beta-hydroxylase inhibitors
AU7922191A (en) 2-acylamino-7-chlorobenzothiazoles